Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (50.0%)
N/A2 (50.0%)

Trials by Status

completed375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

NCT02551068
completedphase_4

Effects of Different Inhalation Oxygen Concentrations on Postoperative Atelectasis

NCT05627024
completednot_applicable

Safe Time for Apnea After Preoxygenation

NCT03239678
withdrawnphase_4

The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy

NCT02509182

Clinical Trials (4)

Showing 4 of 4 trials
NCT02551068Not Applicable

High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

Completed
NCT05627024Phase 4

Effects of Different Inhalation Oxygen Concentrations on Postoperative Atelectasis

Completed
NCT03239678Not Applicable

Safe Time for Apnea After Preoxygenation

Completed
NCT02509182Phase 4

The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4